Staff Reporter
Islamabad
The Drug Regulatory Authority of Pakistan (DRAP), in partnership with the U.S. government, launched an innovative online platform that will enable the Government of Pakistan to more quickly and effectively evaluate the safety and effectiveness of medicine, leading to greater health security in the country.
The Government of Pakistan, in partnership with the US Government through the United States Agency for International Development (USAID), worked together to create the platform to comply with international pharmaceutical standards.
The platform, called the Pakistan Integrated Regulatory Information Management System (PIRIMS), will integrate the registration, inspection, licensing, and monitoring of approved medicines into one platform.
With PIRIMS, regulators can more quickly and effectively monitor medicines in the development and approval processes, and pharmaceutical companies will be able to more quickly and easily apply for permission to produce a medicine.
In the past, it could take several years and cost millions of rupees for a pharmaceutical company to register a drug; that time and cost will now be greatly reduced, allowing Pakistani companies to bring safe, effective medicines to market more quickly and less expensively.
